Evidence map›Paper›PMID 28249852›Full record

Observational studyBMJ open2017

Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway.

Andreas Austgulen Westin, Malin Brekke, Espen Molden, Eirik Skogvoll, Marianne Aadal, Olav Spigset

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Depression Treatment in Pregnancy: Is It Safe, or Is It Not?International journal of environmental research and public health · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Review
  16. Lithium during pregnancy and after delivery: a review.International journal of bipolar disorders · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Andreas Austgulen WestinDepartment of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.ORCID 0000-0002-9198-5137
Malin BrekkeCenter for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
Espen MoldenCenter for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
Eirik SkogvollDepartment of Anaesthesiology and Intensive Care, St. Olav University Hospital, Trondheim, Norway.
Marianne AadalDepartment of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.
Olav SpigsetDepartment of Clinical Pharmacology, St Olav University Hospital, Trondheim, Norway.
Norwegian University of Science and Technology · NOSt Olav's University Hospital · NODiakonhjemmet Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPregnancy may cause changes in drug disposition, dose requirements and clinical response. For lithium, changes in disposition during pregnancy have so far been explored in a single-dose study on 4 participants only. The aim of this study was to determine the effect of pregnancy on serum levels of lithium in a larger patient material in a naturalistic setting.

designA retrospective observational study of patient data from 2 routine therapeutic drug monitoring services in Norway, linked to the Medical Birth Registry of Norway.

settingNorway, October 1999 to December 2011. MEASUREMENTS: Dose-adjusted drug concentrations of lithium during pregnancy were compared with the women's own baseline (non-pregnant) values, using a linear mixed model.

resultsOverall, coupling 196 726 serum concentration measurements from 54 393 women to the national birth registry identified 25 serum lithium concentration analyses obtained from a total of 14 pregnancies in 13 women, and 63 baseline analyses from the same women. Dose-adjusted serum concentrations in the third trimester were significantly lower than baseline (-34%; CI -44% to -23%, p<0.001).

conclusionsPregnancy causes a clinically relevant decline in maternal lithium serum concentrations. In order to maintain stable lithium concentrations during the third trimester of pregnancy, doses generally need to be increased by 50%. Individual variability in decline implies that lithium levels should be even more closely monitored throughout pregnancy and in the puerperium than in non-pregnant women to ensure adequate dosing.

Indexed as

Drug MonitoringAdultAntimanic AgentsBipolar DisorderFemaleHumansLinear ModelsLithium CompoundsNorwayPostpartum PeriodPregnancyPregnancy Trimester, ThirdRetrospective StudiesAntimanic AgentsLithium CompoundsCLINICAL PHARMACOLOGYPSYCHIATRY

Identifiers

PMID28249852
PMCPMC5353288
OpenAlexW2594912242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.